Kenneth R. Deans Jr.
Carolina del Sur
Kenneth R. Deans Jr. es colaborador de The American Quorum. Con más de 30 años de experiencia en puestos de liderazgo en los sectores de la salud, la tecnología y la educación, aporta una perspectiva independiente y basada en su amplia experiencia a los temas que marcan el rumbo de Estados Unidos.
Salud
FDA Approves First Targeted Therapy for IDH1-Mutated Relapsed or Refractory MDS After 38.9% Complete Remission Rate
Tecnología
33 States Sue Meta, Alleging Facebook and Instagram Designs Harm Children and Evade Under-13 Privacy Rules
Salud
FDA Approves Bimzelx for Plaque Psoriasis After Phase 3 Trials Show 85%–91% Clear or Almost Clear Skin
Tecnología
U.S. Tightens AI-Chip Controls on China, Expanding Licensing to Nvidia A800, H800 and RTX 4090
Salud
Medicare Part B Premium Rises 5.9% to $174.70 for 2024 as Social Security COLA Slows to 3.2%
Tecnología
Microsoft Closes $68.7 Billion Activision Blizzard Deal After U.K. Regulator Clears Restructured Acquisition
Salud
Karikó and Weissman Win 2023 Medicine Nobel for mRNA Discoveries That Enabled COVID-19 Vaccines
Tecnología
Amazon Launches First Two Project Kuiper Satellites, Opening a 3,236-Satellite Challenge to Starlink
Salud
FDA Approves Subcutaneous Entyvio After 46% vs. 14% Week-52 Remission in Ulcerative Colitis Trial
Tecnología
Amazon Commits Up to $4 Billion to Anthropic as AWS Becomes Primary Cloud for Future Claude Models
Salud
CDC Recommends Maternal RSV Vaccine at 32–36 Weeks After 11-1 Vote, Adding Second Infant Protection Option
Tecnología
Cisco Agrees to Buy Splunk for $28 Billion, Paying $157 a Share to Expand Security and Observability
Salud
CDC Recommends Updated XBB.1.5 COVID-19 Vaccines for Everyone 6 Months and Older After 13-1 Advisory Vote
Tecnología
Google Search Antitrust Trial Opens as U.S. Challenges Default Deals on Phones and Browsers
Salud
FDA Approves APHEXDA After Phase 3 Trial Shows 92.5% Stem-Cell Mobilization Success in Multiple Myeloma
Tecnología
EU Names Six Big-Tech Gatekeepers and 22 Platform Services Under Digital Markets Act
Salud
Medicare Selects First 10 Drugs for Price Negotiation After $50.5 Billion in Part D Spending
422 stories